Tompkins Financial’s iRadimed IRMD Stock Holding History

Tompkins Financial’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-30	Closed	-$1K	–	429
2016 Q2	$1K	Buy	+30	New	+$540	﹤0.01%	512

Other funds holding IRMD

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.69B AUM

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tompkins Financial's IRMD Position: Q3 2016 in Review

Tompkins Financial sold out of iRadimed (IRMD) in Q3 2016, closing a stake of 30 shares — an estimated $1K sold.

Tompkins Financial first reported a position in IRMD in Q2 2016 and held it in 1 quarter. The position peaked at $1K in Q2 2016. 62 funds tracked by Wall St. Rank hold IRMD as of Q3 2016.

Tompkins Financial reported no remaining iRadimed position as of Q3 2016 after selling out during the quarter.
Tompkins Financial sold 30 iRadimed shares in Q3 2016, an estimated $1K.
Tompkins Financial first reported a position in iRadimed in Q2 2016 and held it in 1 quarter.
Tompkins Financial's iRadimed position peaked at $1K in Q2 2016.
62 funds tracked by Wall St. Rank held iRadimed as of Q3 2016.

Based on Tompkins Financial's 13F filing for Q3 2016, filed 13 Oct 2016.